17.05.2014 03:00:00
|
Abbott Laboratories -- Moody's: Abbott's acquisition of CFR Pharmaceuticals is credit positive; ratings unaffected
New York, May 16, 2014 -- Moody's Investors Service said that Abbott Laboratories' (A1 negative) announced acquisition of CFR Pharmaceuticals S.A. (not rated), a Chilean branded generic pharmaceutical company, is credit positive but has no effect on Abbott's ratings or outlook. For further information, please see Moody's Issuer Comment on Abbott on www.moodys.com.